10x Genomics, Inc.
TARGETED NON-INVASIVE PRENATAL TESTING

Abstract:

The present disclosure relates to methods, compositions and systems for targeted haplotype phasing, SNP identification, and copy number variation assays. Included within this disclosure are methods and systems for combining oligonucleotide barcodes with nucleic acid samples in multiple separate partitions, as well as methods of processing, sequencing and analyzing barcoded samples.